Eris Lifesciences Allots 24,396 Equity Shares Under ESOP-2021 Scheme
Eris Lifesciences Ltd announced the allotment of 24,396 equity shares on May 11, 2026. The transaction was executed following the exercise of options under the ESOP-2021 Scheme.The details of the equity shares allotted across different years and associated issue prices were structured as follows:
| ESOP Scheme | Year of Grant | Number of Equity Shares Allotted | Issue Price Per Share |
|---|---|---|---|
| ESOP-2021 Scheme | 2022 | 6,415 | Rs. 557.24 |
| ESOP-2021 Scheme | 2023 | 8,281 | Rs. 510.32 |
| ESOP-2021 Scheme | 2024 | 9,673 | Rs. 728.16 |
Following the allotment of shares, the paid-up share capital of Eris Lifesciences Limited increased. The capital moved from ₹13,85,42,887 (representing 13,85,42,887 equity shares of ₹1/- each) to ₹13,85,67,256 (representing 13,85,67,256 equity shares of ₹1/- each).
ERIS Stock Price Movement
Shares of Eris Lifesciences Limited are edging higher to ₹1391.6 as of 12:11 PM today, gaining 0.40% in live trading. The stock remains active on a volume of 26,957 shares, trading within the daily range established between ₹1367.1 and ₹1419.5.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.